Publications by authors named "Jason M Low"

Claim this Profile
R
Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.
William F C Rigby, Kathy Lampl, Jason M Low, Daniel E Furst

Int J Rheumatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis.
Jianmei Wang, Jenny Devenport, Jason M Low, Dale Yu, Elena Hitraya

Arthritis Care Res (Hoboken)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
William G Reiss, Jenny N Devenport, Jason M Low, George Wu, Eric H Sasso

Rheumatol Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins.
Jason M Low, Anil K Chauhan, David S Gibson, Mengmeng Zhu, Sixue Chen

Proteomics Clin Appl· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Jason M Low, Anil K Chauhan, Daniel A Kietz, Umar Daud, Peri H Pepmueller

J Rheumatol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis